Tamer Rezk
Overview
Explore the profile of Tamer Rezk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, et al.
JACC Cardiovasc Imaging
. 2019 Jun;
13(1 Pt 1):69-80.
PMID: 31202744
Objectives: This study aimed to assess the diagnostic use of native T1 to detect cardiac amyloidosis (CA) in a large prospective cohort of patients referred for suspected systemic amyloidosis. Background:...
12.
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers
Rezk T, Lachmann H, Fontana M, Naharro A, Sachchithanantham S, Mahmood S, et al.
Br J Haematol
. 2019 May;
186(3):460-470.
PMID: 31124579
Systemic AL amyloidosis is a cause of type 5 cardiorenal syndrome. Response to treatment is currently reported according to organ-specific amyloidosis consensus criteria (ACC), which are not validated in cardiorenal...
13.
Lane T, Fontana M, Martinez-Naharro A, Quarta C, Whelan C, Petrie A, et al.
Circulation
. 2019 May;
140(1):16-26.
PMID: 31109193
Background: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure in older individuals. We sought to characterize the natural history of ATTR-CM and compare outcomes and quality...
14.
Rezk T, Gilbertson J, Mangione P, Rowczenio D, Rendell N, Canetti D, et al.
J Pathol Clin Res
. 2019 Feb;
5(3):145-153.
PMID: 30740936
The tissue diagnosis of amyloidosis and confirmation of fibril protein type, which are crucial for clinical management, have traditionally relied on Congo red (CR) staining followed by immunohistochemistry (IHC) using...
15.
Kotecha T, Martinez-Naharro A, Yoowannakul S, Lambe T, Rezk T, Knight D, et al.
Sci Rep
. 2019 Feb;
9(1):1388.
PMID: 30718606
In patients with chronic kidney disease (CKD), reverse left ventricular (LV) remodelling, including reduction in LV mass, can be observed following long-term haemodialysis (HD) and has been attributed to regression...
16.
Rezk T, Davenport A, Gan J, Lachmann H, Fontana M, Martinez-Naharro A, et al.
Br J Haematol
. 2018 Nov;
185(5):977-980.
PMID: 30450572
No abstract available.
17.
Rowczenio D, Quarta C, Fontana M, Whelan C, Martinez-Naharro A, Trojer H, et al.
Hum Mutat
. 2018 Oct;
40(1):90-96.
PMID: 30328212
Transthyretin amyloidosis (ATTR) is caused by deposition of either wild-type (ATTRwt) or variant (ATTRm) transthyretin. ATTRwt presents with restrictive cardiomyopathy, while ATTRm displays a range of organ involvement. This retrospective...
18.
Manwani R, Sachchithanantham S, Mahmood S, Foard D, Sharpley F, Rezk T, et al.
Blood
. 2018 Jun;
132(7):761-764.
PMID: 29925500
No abstract available.
19.
Knight D, Zumbo G, Barcella W, Steeden J, Muthurangu V, Martinez-Naharro A, et al.
JACC Cardiovasc Imaging
. 2018 Apr;
12(5):823-833.
PMID: 29680336
Objectives: This cross-sectional study aimed to describe the functional and structural cardiac abnormalities that occur across a spectrum of cardiac amyloidosis burden and to identify the strongest cardiac functional and...
20.
George M, Marks D, Rezk T, Breckenridge R, Sofat R, Martin J, et al.
Hypertension
. 2018 Apr;
71(5):772-780.
PMID: 29610269
No abstract available.